Several members of ImmunoConcEpT will attend the French Society of Immunology’s conference: -Julie Déchanet-Merville is invited speaker and will chair a session -Claire Liebler and Marc Scherlinger are invited speakers RDV: September 26-29th, 2023 in STRASBOURG
He will lead project CELLTYPE, which aims to clarify the concept of “cell type” in contemporary biology. About the project: The project starts from the observation that recent developments, especially genomic single cell experiments, have made the concept of cell type, which has never been clearly defined, problematic. The main aim is thus to clarify …
He will be leading the project MEASURAGE, a project on the theoretical framework necessary to correctly measure the progression of aging. Partners are Adrien Barton (Université de Toulouse) and Alan Cohen (Columbia University). About the project: The question of measuring the progression of aging has become crucial. Some think that it might be a predictor …
Together with Judith Favier in Paris Johan Garaude was awarded a grant from the ANR PRCE program for their project SuccINNATE, which aims at studying the emergent role of Succinate Dehydrogenase in the control of inflammatory innate immune responses.
We had our first “la Fresque du Climat” at ImmunoConcEpT which was animated by a colleague from the MFP lab. Many thanks to her! It was a great time during which we learnt a lot of things about climate change and we talked about solutions which we can apply in our professional and personal life. …
The French DC Society is happy to announce that the next international meeting will take place in Bordeaux, France. Title: Development, metabolism and function of dendritic cells and macrophages in health and disease Dates: 7th to 8th December 2023 Where: Université de Bordeaux Pey Berland Registration will start in May 2023 Confirmed Speakers Ido Amit, …
The team of Dr. Blanco has been awarded a grant from the Fondation pour la Recherche Medicale to work on the on a tumor-derived peptide function in the prevention of autoimmune diseases. Excited to start this new project…
Background: Lebrikizumab, a high-affinity IgG4 monoclonal antibody targeting interleukin-13, prevents the formation of the interleukin-4Rα-interleukin-13Rα1 heterodimer receptor signaling complex. Methods: We conducted two identically designed, 52-week, randomized, double-blind, placebo-controlled, phase 3 trials; both trials included a 16-week induction period and a 36-week maintenance period. Eligible patients with moderate-to-severe atopic dermatitis (adults [≥18 years of age] and adolescents …
The group of Dr. Julien Seneschal published a NEJM, congrats Read More »
This detailed volume provides methods that can be used to study dendritic cell (DC) ontogeny, isolation, migration, and functions. After an introduction to murine and human DC subsets and their unique transcriptional, phenotypic, and functional properties, the book continues with sections covering in vivo studies, in vitro differentiation, enrichment, functional characterization, as well as Omics …
A new book on Dendritic Cells protocols edited by Vanja Sisirak Read More »
All right reserved © immunoconcept.cnrs.fr 2023 by Nivo-Web
